Parliamentary summit on better care for arthritis and musculoskeletal conditions
Discover more...
-
Shortage of Abatacept (Orencia®) – update
Update: August 01, 2024. As of August 1, 2024, Bristol Myers Squibb (BMS) has announced the cessation of the Orencia® Stock Hypercare Plan (OSHP) due...
-
Anticipated Shortage of Abatacept (Orencia®)
Bristol Myers Squibb (BMS), the manufacturer of abatacept (Orencia®), has recently announced an expected shortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations...
-
Arthritis Australia, Chronic Pain Australia and Consumers Health Forum of Australia Joint Statement ABC 4 Corners “Pain Factory” episode
Tuesday 9 April 2024 Last night’s episode of ABC 4 Corners highlighted the many adverse events people living with chronic musculoskeletal pain have experienced when...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: